An eosinophilia-myalgia syndrome associated with an L-tryptophan containing product.
A syndrome of eosinophilia and myalgias associated with the usage of L-tryptophan containing products has been recently described by the Centers for Disease Control. We report a case of this new clinical entity, highlighted by severe myositis, and compare this illness with similar reported syndromes.
Saag
K G
KG
Department of Medicine, Evanston Hospital, IL 60201.
Goldschmidt
R
R
Vernof
H
H
Golbus
J
J
D000368:Aged; D001706:Biopsy; D004802:Eosinophilia / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006801:Humans; D009132:Muscles / Q000473:pathology; D009135:Muscular Diseases / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D009220:Myositis / Q000139:chemically induced / Q000473:pathology; D010146:Pain; D013577:Syndrome; D014364:Tryptophan / Q000009:adverse effects*
D014364:Tryptophan